Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) SHH

Currency In CNY

AD

Valuation

Market Cap9.72B
Enterprise Value9.7B
P/E Ratio123.82
PEG Ratio0.04
Price/Sales Ratio25.84
Price/Book Ratio5.75
Enterprise/Revenue25.4
Enterprise/EBITDA126.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.21
Operating Margin0.18
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue317.08M
Revenue/Share1.59
Gross Profit317.08M
EBITDA72.12M
Net Income64.56M
Diluted EPS0.31

Balance Sheet

Total Cash418.22M
Total Cash/Share2.04
Total Debt25.01M
Total Debt/Equity0.02
Current Ratio9.48
Book Value Per Share7.07

Price History

52-Week Change-12.6
52-Week High83.6
52-Week Low38.31
Moving Average 50 Days52.89
Moving Average 200 Days53.14

Statistics

Average Volume5.85M
Shares Outstanding206.7M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor13:10
Last Split DateMay 17, 2024
AD